论文信息 - Consistent efficacy of nivolumab plus ipilimumab across number of International Metastatic Database Consortium (IMDC) risk factors in CheckMate 214. - 字舞流文

Consistent efficacy of nivolumab plus ipilimumab across number of International Metastatic Database Consortium (IMDC) risk factors in CheckMate 214.

C. Porta | R. Motzer | B. Rini | Y. Tomita | B. Escudier | N. Tannir | M. McHenry | S. Mekan